Finding the Right Healthcare Brand Agency

The category has shifted. A treatment center’s brand is no longer a creative artifact evaluated against portfolio aesthetics; it is the primary substrate on which patient choice, referral trust, and admissions economics are built. For behavioral health marketing leaders, that reframes what selecting a healthcare brand agency actually decides.

Patient choice research supports the reframe. In a choice-based conjoint experiment with 949 respondents selecting a primary care physician, nonclinical experience ratings from commercial sources moved provider selection at nearly the same magnitude as government clinical ratings, with both categories emerging as the dominant drivers of choice ¹. The study measured PCP selection, not SUD admissions, and the transfer is not one-to-one. But the underlying mechanism—patients weighting perceived experience against clinical signal—applies with more force in behavioral health, where objective clinical ratings are largely absent from the surfaces families search.

That is the economic exposure. When a prospective patient or family member evaluates a facility at 2 a.m., they are reading reviews, scanning testimonials, and forming a brand judgment before an admissions coordinator ever answers the phone. The agency chosen to shape those signals is functionally choosing the top of the admissions funnel.

The rest of this article treats agency selection as a risk-adjusted growth decision, evaluated against five dimensions tied to admissions math, reputation defense, and regulated-channel operations.

The strongest published evidence on how patients pick a provider comes from a choice-based conjoint experiment by Yaraghi and colleagues, which asked 949 respondents to select a primary care physician under varying rating conditions ¹. Moving a physician’s government clinical rating from 2 to 4 stars increased the relative log-odds of selection by 1.31. Moving a commercial nonclinical rating—patient experience—from 2 to 4 stars increased it by 1.32 ¹. Experience signal and clinical signal pulled patient decisions at nearly identical strength.

Two limits matter. The study measured PCP selection, not addiction treatment admissions, and it tested ratings in a controlled survey rather than in live search behavior. The transfer to behavioral health is inferential, not proven. But the transfer logic is defensible: in SUD and mental health, government clinical star ratings comparable to Medicare’s PCP data are largely absent from the surfaces prospective patients and families actually search. That leaves commercial nonclinical signals—Google reviews, Yelp ratings, testimonial content, third-party rankings—doing more of the decision work, not less.

A qualified agency should be able to describe, in the pitch, which experience signals it will produce, on which surfaces, at what cadence, and how those signals will be measured against inbound call volume. Agencies that talk about brand as identity rather than as a measurable signal system on public rating and review surfaces are optimizing for the wrong variable. The Yaraghi data does not tell a CMO which agency to hire. It tells the CMO what the agency’s work has to move.

The most category-specific evidence available links what patients write about SUD facilities to what happens in the surrounding population. A 2023 cross-sectional analysis of 9,597 Yelp reviews across 589 SAMHSA-designated substance use disorder treatment facilities compared facility ratings and review themes against state-level drug-induced mortality ⁶. Lower facility ratings were associated with higher drug-induced mortality at the state level. Experience themes tied to lower mortality included caring staff and amazing experience (r = −0.23) and individualized recovery programs (r = −0.20) ⁶.

The design limits the conclusion. This is ecological and cross-sectional. Review sentiment does not cause mortality outcomes, and state-level mortality reflects far more than the facilities being reviewed. The correlation is directional evidence, not a treatment effect.

The operational read for a treatment center CMO is still specific. The experience language that shows up in Yelp reviews of SUD facilities is not incidental brand vocabulary. It clusters around clinical culture variables that appear to track with harder outcomes in the same geographies. When a prospective family reads reviews describing individualized programs and caring staff, they are reading signals that correlate with the category’s real-world performance patterns, not just satisfaction noise.

That reframes what a healthcare brand agency in this category is actually managing. Review generation, response protocols, and the narrative content that surfaces alongside review pages are not reputation cosmetics. They are the public representation of clinical culture variables that a systematic review of hospital brand equity identifies as core determinants of perceived quality and patient trust ⁹. An agency that treats reviews as a five-star average to defend—rather than as a corpus of experience language that has to accurately represent the program—is optimizing the wrong surface.

Two practical implications follow. Review response protocols should be built with clinical leadership, not written by marketing coordinators, because the language patterns in responses become part of the facility’s public clinical signal. And the themes an agency proposes to surface in testimonials and narrative content should be auditable against what alumni actually experienced, not selected for search performance alone.

The facility website is where the reputation signals in sections 2 and 3 either compound or dissipate. It is the surface a family lands on after clicking a Google listing, a review link, or an LLM-cited source. If the site fails to represent clinical culture with the same clarity the reviews suggested, the brand equity built on external surfaces leaks on arrival.

The category baseline is documented. A study evaluating the web presence of substance abuse treatment facilities scored sample sites between 4 and 6 out of 10 on average across usability, content quality, and accessibility dimensions ⁷. That is a mid-band score in a category where prospective patients arrive in acute states and family members are making decisions under time pressure. The gap between a 5/10 facility site and a well-executed one is not aesthetic. It is the difference between a legible admissions path and a bounce.

Treating web and UX as brand-equity substrate reframes what an agency is delivering. Perceived quality, brand image, and patient experience—three of the equity drivers identified in the hospital brand equity literature—are expressed through page architecture, load performance, mobile behavior, clarity of clinical modality descriptions, and the visibility of admissions pathways ⁹. A site that hides the phone number below the fold or buries insurance verification behind a form is degrading equity drivers, not just conversion rate.

Diligence should include a technical audit of the agency’s last three behavioral health site launches against the usability, content, and accessibility dimensions the SUD web presence study evaluated ⁷. Agencies that cannot produce measurable score improvements on those dimensions are shipping deliverables, not moving equity.

The category conflates two disciplines that require different operating muscles.

Brand agency

Builds equity drivers—perceived quality, associations, narrative, reputation surface—and measures success against trust signals and search share of voice over quarters.

Performance agency

Buys attention through paid search, paid social, and retargeting, and measures against cost per qualified call inside a monthly window.

Most treatment center CMOs have been burned by one agency claiming both.

The evidence supports skepticism about combined claims. A systematic review of 42 high-quality reviews on social media in health found that while 88.8 percent of primary reviews reported some positive impact on behaviors or outcomes, the underlying evidence quality was modest and heterogeneous ⁵. Agencies that pitch brand-plus-performance as a unified deliverable often lean on the softer end of that evidence base to justify the brand line item while running the performance line as the accountable channel.

Two operating models work in behavioral health.

1. The first uses separate agencies with a CMO-owned integration layer: a shared attribution model, a single call-tracking instance, and a weekly reconciliation between branded search lift and paid acquisition volume.
2. The second uses one agency that can prove both disciplines operate under distinct leads with shared reporting.

Force integration when branded search volume, review sentiment, and paid conversion rate are treated as one connected data set—not when a single account manager owns both P&Ls without a system beneath.

This section shifts scope. The reader here is a portfolio CMO or sponsor-side operating partner managing brand across multiple facilities, often assembled through acquisition, and answering to a private-equity thesis on census and multiple expansion.

Portfolio architecture is a brand decision with operating consequences. The three common structures—single master brand, house of brands, and endorsed brand—each move the equity drivers identified in the hospital brand equity literature (perceived quality, brand image, awareness, associations, patient experience) in different directions, and each carries a different operating cost beneath the strategy ⁹.

The trade-off is legible. A master brand concentrates equity and lowers operating overhead, but a single LegitScript issue, review crisis, or clinical incident propagates across the entire portfolio. A house of brands limits blast radius and preserves the local search equity of acquired facilities—often the most valuable asset in a rollup—at the cost of duplicated reputation infrastructure and paid search compliance work at every site. Endorsed architectures split the difference and are the most common landing point for sponsor-backed operators integrating acquisitions over a three-to-five-year hold.

The agency selection question changes accordingly. A portfolio operator is not hiring for one facility’s brand. It is hiring for the capacity to run review response, narrative production, and regulated paid search at multiplied scale, with a governance layer that keeps facility-level equity drivers visible to the parent ⁹. Ask any agency how many concurrent LegitScript accounts, GBP profiles, and separate call-tracking instances it currently manages for a single client, and how it reconciles brand-equity reporting up to a portfolio dashboard the sponsor can read.

Most behavioral health agency RFPs get answered with the same portfolio deck: identity work, campaign concepts, a testimonial reel, and a case study with a percentage lift and no denominator. The diligence process that filters those decks looks different. It asks agencies to produce operational artifacts before the contract, not aspirational language.

Six questions do most of the work.

1. Ask the agency to name, from a live client’s current data, the weakest brand equity driver and the specific admissions call volume lift it expects to produce over two quarters—perceived quality gaps in reviews, weak local search associations, or referral partner failures are acceptable answers; a creative platform is not ⁹.
2. Request the review response protocol and the name of the clinical leader who reviews language before it publishes.
3. Ask for a walkthrough of the GA4 or server-side attribution configuration the agency uses to preserve admissions call tracking under Google’s healthcare policies, and its documented response to a LegitScript recertification lapse.
4. Ask what share of admissions the agency attributes to brand channels versus performance channels for at least one live behavioral health client, and how the attribution was constructed against the CRM.
5. Request three narrative pieces produced for a former client and a reference call with that client’s clinical leadership to verify the work represented the program accurately ⁶.
6. Ask which staff member owns platform relationships when a Google Ads account is suspended, and how the agency monitors LLM answer summaries of client facilities for misrepresentation ³.

Agencies that answer these in specifics have run the plays. Agencies that answer in category language are selling the deck.